{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:33:00Z","timestamp":1754145180663,"version":"3.41.2"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cellimm.2025.104991","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T10:54:02Z","timestamp":1749293642000},"page":"104991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel approach to hematopoietic stem cell transplantation: The effect of CMV infection and HLA genotypes on chimerism status in Egyptian patients"],"prefix":"10.1016","volume":"414","author":[{"given":"Raghda Mohammed","family":"Ghorab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala Ahmed","family":"Talkhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa Mohamed Abd","family":"ElGwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania AbdelMoniem","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda Ezz Elarab","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa Mohamed","family":"Abd El Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.cellimm.2025.104991_bb0005","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood.V126.23.5446.5446","article-title":"Cytomegalovirus and effect on early chimerism in patients with myeloid disorders undergoing stem cell transplantation using reduced toxicity ablative conditioning regimen","volume":"126","author":"Farhan","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cellimm.2025.104991_bb0010","first-page":"51","article-title":"HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant","volume":"67","author":"Ghobadi","year":"2019","journal-title":"Curr. Res. Transl. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0015","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2016-04-713644","article-title":"Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia","volume":"128","author":"Elmaagacli","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cellimm.2025.104991_bb0020","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cellimm.2025.104991_bb0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/1110-1067.186413","article-title":"Human leukocyte antigen HLA-BR16 is associated with reduced risk for cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"El-Ghammaz","year":"2016","journal-title":"Egypt. J. Haematol."},{"issue":"1","key":"10.1016\/j.cellimm.2025.104991_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/JCM.41.1.187-191.2003","article-title":"Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients","volume":"41","author":"Li","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4274\/Tjh.2013.0244","article-title":"Factors associated with cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation: human leukocyte antigens might be among the risk factors","volume":"31","author":"Acar","year":"2014","journal-title":"Turk. J. Haematol."},{"issue":"2","key":"10.1016\/j.cellimm.2025.104991_bb0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood.V98.2.500","article-title":"Relationship between HLA alleles and cytomegalovirus infection after allogenic hematopoietic stem cell transplant","volume":"98","author":"Chen","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellimm.2025.104991_bb0045","first-page":"34","article-title":"Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation","volume":"5","author":"Fan","year":"2006","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"4","key":"10.1016\/j.cellimm.2025.104991_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13879","article-title":"Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Prem","year":"2022","journal-title":"Transpl. Infect. Dis."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0055","doi-asserted-by":"crossref","first-page":"181 e1","DOI":"10.1016\/j.jtct.2022.12.005","article-title":"Effect of CD34(+) cell dose on the outcomes of allogeneic stem cell transplantation with post-transplantation cyclophosphamide","volume":"29","author":"Pedraza","year":"2023","journal-title":"Transplant. Cell Ther."},{"issue":"9","key":"10.1016\/j.cellimm.2025.104991_bb0060","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.62347\/SOPM3064","article-title":"CD34+ cell dose and CMV viremia after haploidentical hematopoietic stem cell transplantation: a retrospective study","volume":"16","author":"Yan","year":"2024","journal-title":"Am. J. Transl. Res."},{"issue":"21","key":"10.1016\/j.cellimm.2025.104991_bb0065","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1182\/blood.V124.21.1212.1212","article-title":"Clinical outcomes of 2-step approach to haploidentical hematopoietic stem cell transplantation (HSCT): effects of CD34 stem cell dose in the setting of a consistent T-cell dose","volume":"124","author":"Gaballa","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellimm.2025.104991_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"10.1016\/j.cellimm.2025.104991_bb0075","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood.V77.7.1607.1607","article-title":"Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation","volume":"77","author":"Ugozzoli","year":"1991","journal-title":"Blood"},{"year":"2016","series-title":"State of Chimerism as a Promising Tool for Follow up of Hematopoietic Stem Cell Transplantation in Egyptian Patients","author":"Talkhan","key":"10.1016\/j.cellimm.2025.104991_bb0080"},{"key":"10.1016\/j.cellimm.2025.104991_bb0085","series-title":"The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies","article-title":"Documentation of engraftment and chimerism after HCT","author":"Bader","year":"2024"},{"issue":"1","key":"10.1016\/j.cellimm.2025.104991_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13287-024-03726-z","article-title":"Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?","volume":"15","author":"Rostami","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"25","key":"10.1016\/j.cellimm.2025.104991_bb0095","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2025.104991_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3947\/ic.2024.0140","article-title":"How should cytomegalovirus infection be managed in allogeneic hematopoietic stem cell transplant recipients? A clinical grand round","volume":"57","author":"Nho","year":"2025","journal-title":"Infect. Chemother."},{"issue":"11","key":"10.1016\/j.cellimm.2025.104991_bb0105","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.bbmt.2011.08.014","article-title":"Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies","volume":"17","author":"Munoz-Cobo","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.cellimm.2025.104991_bb0110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bbmt.2009.12.003","article-title":"An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation","volume":"16","author":"Tormo","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.cellimm.2025.104991_bb0115","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cellimm.2025.104991_bb0120","doi-asserted-by":"crossref","first-page":"S453","DOI":"10.1016\/j.jtct.2023.12.657","article-title":"Impact of high dose acyclovir prophylaxis for the prevention of cytomegalovirus reactivation after pediatric allogeneic stem cell transplant","volume":"30","author":"Long","year":"2024","journal-title":"Transplant. Cell. Ther."},{"issue":"11","key":"10.1016\/j.cellimm.2025.104991_bb0125","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41409-023-02081-6","article-title":"High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience","volume":"58","author":"Kabut","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmii.2021.01.001","article-title":"Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: a mini-review","volume":"54","author":"Jerry Teng","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.cellimm.2025.104991_bb0135","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fonc.2019.00888","article-title":"The presence of a CMV Immunodominant allele in the recipient is associated with increased survival in CMV positive patients undergoing haploidentical hematopoietic stem cell transplantation","volume":"9","author":"Grosso","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellimm.2025.104991_bb0140","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3389\/fimmu.2017.01591","article-title":"Comprehensive analysis of cytomegalovirus pp65 antigen-specific CD8(+) T cell responses according to human leukocyte antigen class I allotypes and intraindividual dominance","volume":"8","author":"Hyun","year":"2017","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2025.104991_bb0145","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.bmt.1705133","article-title":"Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation","volume":"36","author":"Morita","year":"2005","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.cellimm.2025.104991_bb0150","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/j.transproceed.2009.04.017","article-title":"Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience","volume":"41","author":"Kekik","year":"2009","journal-title":"Transplant. Proc."},{"issue":"18","key":"10.1016\/j.cellimm.2025.104991_bb0155","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1128\/JVI.00936-09","article-title":"The efficacy of antigen processing is critical for protection against cytomegalovirus disease in the presence of viral immune evasion proteins","volume":"83","author":"Holtappels","year":"2009","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.cellimm.2025.104991_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003383","article-title":"Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion","volume":"9","author":"Ameres","year":"2013","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.cellimm.2025.104991_bb0165","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/S0041-1345(03)00513-X","article-title":"HLA-DR11 in addition to donor age, gender, and major blood group incompatibility influence the incidence of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"35","author":"Bogunia-Kubik","year":"2003","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.cellimm.2025.104991_bb0170","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4103\/0366-6999.206356","article-title":"Impact of human leukocyte antigen loci and haplotypes on intestinal acute graft-versus-host disease after human leukocyte antigen-matched sibling peripheral blood stem cell transplantation","volume":"130","author":"Yan","year":"2017","journal-title":"Chin. Med. J."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1365-2141.2002.03924.x","article-title":"An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation","volume":"119","author":"Remberger","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.cellimm.2025.104991_bb0180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3324\/haematol.2015.136903","article-title":"High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation","volume":"101","author":"Morishima","year":"2016","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.cellimm.2025.104991_bb0185","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/ajt.15515","article-title":"Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): a systematic review, meta-analysis, and meta-regression analysis","volume":"19","author":"Gimenez","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.cellimm.2025.104991_bb0190","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.bbmt.2014.08.010","article-title":"Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review","volume":"20","author":"Sousa","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"year":"2018","series-title":"New Drug Therapy Approvals 2017","author":"Administration, U.S.F.a.D","key":"10.1016\/j.cellimm.2025.104991_bb0195"},{"key":"10.1016\/j.cellimm.2025.104991_bb0200","series-title":"National Comprehensive Cancer Network: Plymouth Meeting, PA","article-title":"NCCN Clinical Practice Guidelines in Oncology: Prevention and Treatment of Cancer-Related Infections","author":"Network, N.C.C","year":"2024"},{"issue":"4","key":"10.1016\/j.cellimm.2025.104991_bb0205","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41409-023-01920-w","article-title":"Cytomegalovirus breakthrough and resistance during letermovir prophylaxis","volume":"58","author":"Perchetti","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.cellimm.2025.104991_bb0210","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/infdis\/jiad386","article-title":"Cytomegalovirus viral load threshold to guide preemptive therapy in hematopoietic cell transplant recipients: correlation with cytomegalovirus disease","volume":"229","author":"Sadowska-Klasa","year":"2024","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0215","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12185-014-1510-5","article-title":"Chimerism status is correlated to acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"99","author":"Jiang","year":"2014","journal-title":"Int. J. Hematol."},{"issue":"25","key":"10.1016\/j.cellimm.2025.104991_bb0220","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1182\/blood-2008-09-176594","article-title":"Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation","volume":"113","author":"Clave","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cellimm.2025.104991_bb0225","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.exphem.2005.06.016","article-title":"Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation","volume":"33","author":"Jimenez","year":"2005","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.cellimm.2025.104991_bb0230","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood-2014-07-589150","article-title":"CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status","volume":"125","author":"Sellar","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cellimm.2025.104991_bb0235","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbmt.2017.03.027","article-title":"Possible impact of cytomegalovirus-specific CD8(+) T cells on immune reconstitution and conversion to complete donor chimerism after allogeneic stem cell transplantation","volume":"23","author":"Ogonek","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213739","article-title":"Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation","volume":"14","author":"Varanasi","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellimm.2025.104991_bb0245","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1083-8791(03)00077-6","article-title":"Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation","volume":"9","author":"Dey","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0250","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood-2003-07-2344","article-title":"Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning","volume":"103","author":"Bethge","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellimm.2025.104991_bb0255","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2011.08944.x","article-title":"Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure","volume":"156","author":"Mohamedbhai","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.cellimm.2025.104991_bb0260","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1083-8791(00)70014-0","article-title":"Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma","volume":"6","author":"Orsini","year":"2000","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104991_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119595","article-title":"Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission","volume":"10","author":"van der Torren","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellimm.2025.104991_bb0270","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/655472","article-title":"Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature","volume":"202","author":"van de Berg","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cellimm.2025.104991_bb0275","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1128\/JVI.00873-11","article-title":"Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses","volume":"86","author":"Lachmann","year":"2012","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.cellimm.2025.104991_bb0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2042-4280-2-6","article-title":"Cytomegalovirus-induced immunopathology and its clinical consequences","volume":"2","author":"Varani","year":"2011","journal-title":"Herpesviridae"},{"issue":"10","key":"10.1016\/j.cellimm.2025.104991_bb0285","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1704235","article-title":"Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients","volume":"32","author":"Fallen","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"Suppl. 2","key":"10.1016\/j.cellimm.2025.104991_bb0290","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.htct.2022.01.006","article-title":"Prognostic factors and impact of CMV reactivation on acute myeloid leukemia patients after HLA-matched myeloablative allogeneic stem cell transplantation in a high CMV prevalence country","volume":"45","author":"Chanswangphuwana","year":"2023","journal-title":"Hematol. Transfus. Cell Ther."},{"issue":"2","key":"10.1016\/j.cellimm.2025.104991_bb0295","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14160","article-title":"The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia","volume":"35","author":"Xu","year":"2021","journal-title":"Clin. Transpl."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874925000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874925000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T16:20:24Z","timestamp":1752682824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874925000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":59,"alternative-id":["S0008874925000772"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2025.104991","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel approach to hematopoietic stem cell transplantation: The effect of CMV infection and HLA genotypes on chimerism status in Egyptian patients","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2025.104991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104991"}}